Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?
Khalili D, Khayamzadeh M, Kohansal K, et al.
BMC Endocr Disord. 2023;23(1):39.
Leggi
Breaking news
Prevalence of albuminuria among adults with diabetes and preserved estimated glomerular filtration rate by race and ethnicity
Nwosu UA, Darbinian JA, Chen KK, et al.
Diabetes Care. 2023;46(3):e78-e80.
Leggi
Fracture risks associated with sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: a population-based study in Hong Kong
Lui DTW, Wu T, Tang EHM, et al.
Diabetes Res Clin Pract. 2023;110576.
Leggi
La gestione del paziente adulto con diabete o con iperglicemia ricoverato in setting clinico non critico
Linea Guida della Società Italiana di Medicina Interna (SIMI), della Associazione dei Medici Diabetologi (AMD), della Società Italiana di Diabetologia (SID), della Federazione delle Associazioni dei Dirigenti Ospedalieri Internisti (FADOI), della Società Italiana di Gerontologia e Geriatria (SIGG) e dell’Associazione Nazionale Infermieri di Medicina (ANIMO)
Leggi
Impact of changes in diabetes screening guidelines on testing eligibility and potential yield among adults without diagnosed diabetes in the United States
Ali MK, Imperatore G, Benoit SR, et al.
Diabetes Res Clin Pract. 2023;197:110572.
Leggi
Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials
Heerspink HJL, Apperloo E, Davies M, et al.
Diabetes Care. 2023;dc221889.
Leggi
Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population‐based cohort study
Islam N, Reynier P, Douros A, et al.
Diabetes Obes Metab. Pub. online 1 Feb 2023.
Leggi
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial
Gullaksen S, Vernstrøm L, Sørensen SS, et al.
Diabetologia. Pub. online 6 Feb 2023.
Leggi
Extended use of an open-source automated insulin delivery system in children and adults with type 1 diabetes: The 24-week continuation phase following the CREATE randomized controlled trial
Burnside M, Lewis D, Crocket H, et al.
Diabetes Technol Ther. Pub. online 10 Feb 2023.
Leggi
Islet autoantibody standardization program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
Marzinotto I, Pittman DL, Williams AJK, et al.
Diabetologia. Pub. online 10 Feb 2023.
Leggi